This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer–related or all-cause mortality but results likely due to heterogeneity – the two highest quality studies identified do find prostate cancer–related mortality reductions. Issue 1 (12th January 2011)
Record Type:
Journal Article
Title:
Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer–related or all-cause mortality but results likely due to heterogeneity – the two highest quality studies identified do find prostate cancer–related mortality reductions. Issue 1 (12th January 2011)
Main Title:
Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer–related or all-cause mortality but results likely due to heterogeneity – the two highest quality studies identified do find prostate cancer–related mortality reductions
Abstract : Commentary on: Djulbegovic M Beyth RJ Neuberger MM . Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials . BMJ 2010 ;341 :c4543 .